Immix Biopharma Inc.

NASDAQ: IMMX · Real-Time Price · USD
2.27
0.08 (3.65%)
At close: Aug 15, 2025, 3:59 PM
2.27
0.00%
After-hours: Aug 15, 2025, 04:27 PM EDT

Immix Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-23.13M -20.9M -21.69M -21.96M -19.16M -18.36M -15.53M -14.24M -11.43M -9.4M -8.23M -27.19M -26.05M -24.7M -24.38M -2.39M -2.11M -2.03M
Depreciation & Amortization
206.26K 150.72K 115.39K 77.13K 52.6K 28.81K 5.47K 2.96K 2.14K 2.02K 2.13K 2.19K 2.24K 2.48K 2.47K 2.43K 2.39K 2.35K
Stock-Based Compensation
2.84M 2.95M 3.02M 3.37M 3.37M 3.18M 2.57M 1.74M 1.17M 788.91K 524.07K 416.13K 314.8K 279.81K 218.98K 96.83K 34.97K 4.25K
Other Working Capital
638.94K 680.85K 537.2K 1.04M 1.2M -296.3K -11.01K -2.01M -2.26M -627.73K -826.31K -169.04K -355.95K -675.02K -284.97K 248.47K 247.05K 259.69K
Other Non-Cash Items
n/a -12.91K -12.91K 589.89K 1.2M 672.16K 866.1K 295.42M 294.86M 296.02M 295.76M 624.31K 594.43K -2.19K 118.16K 676.54K 665.2K 505.08K
Deferred Income Tax
n/a n/a n/a -668.67K -1.27M -738.02K -931.97K -295.42M -294.81M -295.35M -295.16M 22.11M 22.11M 22.02M 22.85M 735K 735K 825K
Change in Working Capital
7.57M 5.36M 3.97M 2.8M 967.43K 2.11M 1.65M -105.89K -765.63K 499.29K 195.21K -79.21K 331.89K -478.17K -391.04K 567.06K 341.17K 278.45K
Operating Cash Flow
-12.51M -12.45M -14.6M -15.8M -14.85M -13.11M -11.37M -12.6M -10.97M -8.01M -7.41M -4.62M -3.21M -2.82M -1.59M -316.28K -337.24K -425.19K
Capital Expenditures
-974.04K -943.48K -1.18M -683.71K -451.08K -354K -52.09K -38.91K n/a n/a n/a 802.00 802.00 802.00 n/a -802 -802 -802
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-974.04K -943.48K -1.18M -683.71K -451.08K -354K -52.09K -38.91K -2.91M -2.91M -2.91M -2.91M 802.00 802.00 n/a -802 -802 -802
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 100K 200K 200K 200K 100K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a -44K -44K -99.96K -99.96K -55.96K -55.96K n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
15.95M 15.95M 15.95M 5.11K -53.69K -244.51K -232K 233.66K 3.21M 3.35M 3.33M 21.58M 18.65M 18.68M 18.65M -71.02K -52.67K -35K
Financial Cash Flow
1.11M n/a 15.95M 16.54M 26.6M 31.29M 15.46M 15.3M 8.15M 3.35M 6.15M 24.44M 21.51M 21.7M 18.85M 128.98K 147.33K 65K
Net Cash Flow
-12.34M -13.4M 172.17K 108.01K 11.32M 17.86M 4.07M 2.67M -5.75M -7.6M -4.21M 16.88M 18.29M 18.88M 17.25M -150.04K -143.41K -313.22K
Free Cash Flow
-13.48M -13.4M -15.77M -16.48M -15.3M -13.46M -11.42M -12.64M -10.97M -8.01M -7.41M -4.62M -3.21M -2.82M -1.59M -317.08K -338.04K -425.99K